196 results
ARS
2023 FY
MYGN
Myriad Genetics, Inc.
17 Apr 24
Annual report to shareholders
4:33pm
to GeneSight among front-line providers of mental health treatment, including primary care physicians and nurse practitioners who treat the majority … for assessing the conformity of IVDs before they are placed on the EU market. Under the Directive, the majority of IVDs could be placed on the market
8-K
EX-99.1
vqp2 jlqpiu8v
16 Jan 24
Results of Operations and Financial Condition
9:00am
424B5
tmyc 9kxrgg9b2re1e9c
13 Nov 23
Prospectus supplement for primary offering
6:02am
424B5
joyuuddmku
8 Nov 23
Prospectus supplement for primary offering
4:05pm
S-3ASR
iu8 gxlru
8 Nov 23
Automatic shelf registration
4:01pm
S-3ASR
EX-4.3
2b44keffzb8hb
8 Nov 23
Automatic shelf registration
4:01pm
8-K
EX-99.1
3f65r7xl
6 Nov 23
Results of Operations and Financial Condition
4:05pm
8-K
pxfz0lp 3sbett1bgns
3 Aug 23
Results of Operations and Financial Condition
4:05pm
8-K
EX-99.1
0ezz euuujdtf2eww
3 Aug 23
Results of Operations and Financial Condition
4:05pm
8-K
EX-10.2
u8jc5y d1se0j8m
6 Jul 23
Entry into a Material Definitive Agreement
8:24am
8-K
EX-10.1
4mknctw362p48ndg
6 Jul 23
Entry into a Material Definitive Agreement
8:24am